KMTS Stock Analysis — KESTRA MEDICAL TECHNOLOGIES, LTD. COMMON STOCK (Healthcare >> Medical Instruments & Supplies)
KMTS FAQ
What is KMTS's ROE?
KESTRA MEDICAL TECHNOLOGIES, LTD. COMMON STOCK reports a Return on Equity (ROE) of -50.69%.
What is KMTS's dividend yield?
KESTRA MEDICAL TECHNOLOGIES, LTD. COMMON STOCK offers a dividend yield of 0.00%.
What is KMTS's Quality Score?
Our AI rates KMTS's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy KMTS?
Our AI Timing Score for KMTS is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does KMTS belong to?
KESTRA MEDICAL TECHNOLOGIES, LTD. COMMON STOCK is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange
KMTS AI Analysis Summary
Our AI summary for KMTS: KESTRA MEDICAL TECHNOLOGIES, LTD. COMMON STOCK (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 0.00, ROE of -50.69%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 22.83
Price
-0.32
(-1.38%)
Day Change
|
|
|---|
KMTS, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 22.83 |
| PBV / Sector |
5.13 / 3.37
|
| Earning Per Share | -2.25 |
| PE / Sector |
N/A / 44.25
|
| PEG or PE/Growth / Sector |
N/A / -1.35
|
| Average 1M Daily Value |
9.79 M
|
| Average 1W Daily Value |
6.82 M
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:05 |
| Symbol | KMTS |
| Name | KESTRA MEDICAL TECHNOLOGIES, LTD. COMMON STOCK |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 58.60 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,333.20 / 16,159.14 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3933 Lake Washington Blvd NE, Kirkland, WA, United States, 98033
Phone: 425 279 8002
Website: https://kestramedical.com
Employees: 443
Description: Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › Medical Instruments & SuppliesAnalysed on the same criteria, ordered by market cap
Google